Department of Integrated Science and Engineering for Sustainable Society, Faculty of Science and Engineering, Chuo University, Tokyo, Japan.
Center for Epidemiologic Research in Asia, Shiga University of Medical Science, Otsu, Japan.
Hypertens Res. 2019 Apr;42(4):567-579. doi: 10.1038/s41440-019-0220-z. Epub 2019 Feb 13.
To develop a risk chart or score that is based on recent data and applicable to the Japanese people, we need a large cohort study representative of the Japanese people without a need for long-term follow-up. The purpose of the present study was to develop a risk scoring system to estimate the 5- and 10-year absolute and cumulative incidence risk of stroke and acute myocardial infarction (AMI), composite outcome of stroke and AMI, and death from all cardiovascular disease (CVD). The cumulative incidence risk ratios were calculated using a multiple Poisson regression model and data from the Japan Arteriosclerosis Longitudinal Study, which included 67,969 men and women aged 40-89 years. An absolute risk scoring system for 5- and 10-year risk was developed. For blood pressure categories, the risk ratios for all outcomes increased from normal blood pressure (systolic blood pressure (SBP) 120-129 mmHg and diastolic blood pressure (DBP) 80-89 mmHg) to grade III hypertension (SBP ≥ 180 and/or DBP ≥ 110) based on the 2014 Guidelines for the Management of Hypertension compared to the reference optimal blood pressure (SBP < 120 and DBP < 80). Grade II (SBP 160-179 and/or DBP 100-109) and III hypertension treated with medication showed a lower risk compared to counterparts without medication. Other risk factors showed reasonable figures. The total of scores for each risk factor indicated the estimated absolute risk for stroke and AMI, the composite outcome of stroke and AMI, and all CVD. This scoring system may contribute to patient education and to the development of strategies for reducing CVD in the population.
为了制定基于最新数据且适用于日本人的风险图表或评分,我们需要一项具有代表性的、无需长期随访的大规模日本人群队列研究。本研究旨在开发一种风险评分系统,以评估 5 年和 10 年卒中和急性心肌梗死(AMI)、卒中和 AMI 复合结局以及所有心血管疾病(CVD)的绝对和累计发病风险。使用多泊松回归模型和日本动脉硬化纵向研究的数据(包括 67969 名 40-89 岁的男性和女性)计算了累计发病风险比。开发了用于评估 5 年和 10 年风险的绝对风险评分系统。对于血压类别,与参考最佳血压(SBP < 120 和 DBP < 80)相比,所有结局的风险比均从正常血压(SBP 120-129mmHg 和 DBP 80-89mmHg)升高至 2014 年高血压管理指南中的 3 级高血压(SBP ≥ 180mmHg 和/或 DBP ≥ 110mmHg)。与未用药相比,药物治疗的 2 级(SBP 160-179mmHg 和/或 DBP 100-109mmHg)和 3 级高血压的风险较低。其他风险因素显示出合理的数值。每个风险因素的得分总和表示卒中与 AMI、卒中和 AMI 复合结局以及所有 CVD 的估计绝对风险。该评分系统有助于患者教育和制定人群 CVD 降低策略。